With an unparalleled combination of expertise in histopathology and cytology and coupled with the latest molecular diagnostics, we are in a unique position to support the need for specialist diagnostic services.
We provide immunohistochemistry (IHC) and immunocytochemistry (ICC) assays, in situ hybridisation (ISH) and circulating tumour cell (CTC) enumeration, in addition to a broad portfolio of gene-based assays and mutation status testing including KRAS, which is provided free of charge to all NHS customers.
Also available is a Rapid™ HPV testing service, which eliminates the complexity and expense of in-house testing with results typically returned within 24 hours of sample receipt.
A number of the molecular diagnostic tests are companion tests for approved cancer drugs. These tests are available to PharmaBiotech clients in support of clinical trials and clinical research projects. We offer most of these tests in multiple formats, using different technologies, to accommodate the client's regulatory and budgetary requirements. Find out more about companion diagnostics.
Find out more about our tests
How to order